Therapeutic Devices · Redwood City, CA · Founded 2015 · Privately Held (backing)
Developer of energy-based medical device technology designed to improve biological processes. Galvanize Therapeutics is based in Redwood City, CA and was founded in 2015. Its last reported valuation was $300 million in Mar 2022. It has raised $206 million across 4 recorded rounds; the latest was a $100 million Series C in Jul 2025.
Last reported valuation
$300.0M
Oct 2026
Priced at
—
Total raised
$206.1M
Last round
Later Stage VC (Series C)
Jul 2025
No prints on record
No secondary trades in Galvanize Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Galvanize Therapeutics stock.
